UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America

Archives of Endocrinology and Metabolism, 2019-09, Vol.63 (5), p.462-469

2019

Link zum Volltext

Verfügbarkeit prüfen

Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experience

Endocrine, 2023-04, Vol.80 (1), p.134-141

2023

Link zum Volltext

Verfügbarkeit prüfen

Timing of multikinase inhibitor initiation in differentiated thyroid cancer

Endocrine-related cancer, 2017-05, Vol.24 (5), p.237-242

2017

Link zum Volltext

Verfügbarkeit prüfen

Active Surveillance of Small Metastatic Lymph Nodes as an Alternative to Surgery in Selected Patients with Low-Risk Papillary Thyroid Cancer: A Retrospective Cohort Study

Thyroid (New York, N.Y.), 2022-10, Vol.32 (10), p.1178

2022

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems

Thyroid (New York, N.Y.), 2013-11, Vol.23 (11), p.1401

2013

Link zum Volltext

Verfügbarkeit prüfen

The experience of an Endocrinology Division on the use of tyrosine multikinase inhibitor therapy in patients with radioiodine-resistant differentiated thyroid cancer

Endocrine, 2019-06, Vol.64 (3), p.632-638

2019

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of patients with bone metastases from differentiated thyroid cancer

Archives of Endocrinology and Metabolism, 2018-02, Vol.62 (1), p.14-20

2018

Link zum Volltext

Verfügbarkeit prüfen

Dramatic clinical response to dabrafenib plus trametinib in anaplastic thyroid carcinoma and the challenges faced during the COVID-19 pandemic

Archives of Endocrinology and Metabolism, 2021-03, Vol.65 (2), p.242-247

2021

Link zum Volltext

Verfügbarkeit prüfen

Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of Recurrence

Thyroid (New York, N.Y.), 2015-11, Vol.25 (11), p.1235

2015

Link zum Volltext

Verfügbarkeit prüfen

Rare complications of multikinase inhibitor treatment

Archives of Endocrinology and Metabolism, 2018-12, Vol.62 (6), p.636-640

2018

Link zum Volltext

Verfügbarkeit prüfen

Biochemical persistence in thyroid cancer: is there anything to worry about?

Endocrine, 2014-08, Vol.46 (3), p.532-537

2014

Link zum Volltext

Verfügbarkeit prüfen

Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSH

Endocrine, 2017, Vol.55 (1), p.200-208

2017

Link zum Volltext

Verfügbarkeit prüfen

Insulin resistance is another factor that increases the risk of recurrence in patients with thyroid cancer

Endocrine, 2015-04, Vol.48 (3), p.894-901

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of historic histopathologic sample review on the risk of recurrence in patients with differentiated thyroid cancer

Archives of Endocrinology and Metabolism, 2018-03, Vol.62 (2), p.157-163

2018

Link zum Volltext

Verfügbarkeit prüfen

Dynamic prediction of the risk of recurrence in patients over 60 years of age with differentiated thyroid carcinoma

Archives of Endocrinology and Metabolism, 2016-08, Vol.60 (4), p.348-354

2016

Link zum Volltext

Verfügbarkeit prüfen

Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma

Metabolic syndrome and related disorders, 2009-08, Vol.7 (4), p.375

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of hypercortisolism control on high blood pressure in Cushing's syndrome

Medicina (Buenos Aires), 2007, Vol.67 (5), p.439-444

2007

Link zum Volltext

Verfügbarkeit prüfen

Optimum recombinant human thyrotropin dose in patients with differentiated thyroid carcinoma and end-stage renal disease

Endocrine practice, 2008-11, Vol.14 (8), p.961-966

2008

Link zum Volltext

Verfügbarkeit prüfen

Recombinant human TSH versus thyroid hormone withdrawal

Journal of Nuclear Medicine, 2012-11, Vol.53 (11), p.1815-1816

2012

Link zum Volltext

Verfügbarkeit prüfen

Response to sorafenib treatment in advanced metastatic thyroid cancer

Arquivos brasileiros de endocrinologia e metabologia, 2014-02, Vol.58 (1), p.37-41

Pitoia, Fabian

2014

Link zum Volltext

Verfügbarkeit prüfen

Is radioiodine ablation with 1.1 GBq (30 mCi) 131 I necessary in low-risk thyroid cancer patients? Results from a long-term follow-up prospective study

Endocrine, 2023-06, Vol.80 (3), p.606

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris

Medicina (Buenos Aires), 2005, Vol.65 (4), p.307-310

2005

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Survival and Low Effective Cumulative Radioiodine Doses to Achieve Remission in Patients With 131Iodine-Avid Lung Metastasis From Differentiated Thyroid Cancer

Clinical nuclear medicine, 2014-09, Vol.39 (9), p.784-790

2014

Link zum Volltext

Verfügbarkeit prüfen

A study of 34 cases of adrenal incidentaloma

Medicina (Buenos Aires), 2007, Vol.67 (4), p.341-350

2007

Link zum Volltext

Verfügbarkeit prüfen

Primary thyroid disorders in endogenous Cushing's syndrome

European journal of endocrinology, 2002-09, Vol.147 (3), p.305

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(33)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(33)
Female
(32)
Middle Aged
(27)
Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Adult
(25)
Aged
(20)
Endocrinology & Metabolism
(18)
Retrospective Studies
(16)
Thyroid Neoplasms - Pathology
(16)
Adolescent
(13)
Medicine, General & Internal
(13)
Treatment Outcome
(10)
Follow-Up Studies
(9)
Iodine Radioisotopes - Therapeutic Use
(9)
Thyroid Neoplasms - Drug Therapy
(9)
Young Adult
(8)
Endocrinology
(7)
General & Internal Medicine
(7)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(33)
EZB Electronic Journals Library
(14)
Ingenta
(11)
Journals@Ovid
(10)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(7)
IngentaConnect Journals
(7)
Springer journals
(7)
NUS Single-Journal Subscriptions
(2)
Oxford journals
(1)

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America

Dabrafenib plus trametinib treatment in patients with anaplastic thyroid carcinoma: an Argentinian experience

Timing of multikinase inhibitor initiation in differentiated thyroid cancer

Active Surveillance of Small Metastatic Lymph Nodes as an Alternative to Surgery in Selected Patients with Low-Risk Papillary Thyroid Cancer: A Retrospective Cohort Study

Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems

The experience of an Endocrinology Division on the use of tyrosine multikinase inhibitor therapy in patients with radioiodine-resistant differentiated thyroid cancer

Outcomes of patients with bone metastases from differentiated thyroid cancer

Dramatic clinical response to dabrafenib plus trametinib in anaplastic thyroid carcinoma and the challenges faced during the COVID-19 pandemic

Implementing the Modified 2009 American Thyroid Association Risk Stratification System in Thyroid Cancer Patients with Low and Intermediate Risk of Recurrence

Rare complications of multikinase inhibitor treatment

Biochemical persistence in thyroid cancer: is there anything to worry about?

Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSH

Insulin resistance is another factor that increases the risk of recurrence in patients with thyroid cancer

Impact of historic histopathologic sample review on the risk of recurrence in patients with differentiated thyroid cancer

Dynamic prediction of the risk of recurrence in patients over 60 years of age with differentiated thyroid carcinoma

Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma

Effect of hypercortisolism control on high blood pressure in Cushing's syndrome

Optimum recombinant human thyrotropin dose in patients with differentiated thyroid carcinoma and end-stage renal disease

Recombinant human TSH versus thyroid hormone withdrawal

Response to sorafenib treatment in advanced metastatic thyroid cancer

Is radioiodine ablation with 1.1 GBq (30 mCi) 131 I necessary in low-risk thyroid cancer patients? Results from a long-term follow-up prospective study

Prevalence of thyroid autoimmunity in patients with pemphigus vulgaris

Long-Term Survival and Low Effective Cumulative Radioiodine Doses to Achieve Remission in Patients With 131Iodine-Avid Lung Metastasis From Differentiated Thyroid Cancer

A study of 34 cases of adrenal incidentaloma

Primary thyroid disorders in endogenous Cushing's syndrome

Aktive Filter

Suchergebnisse filtern